Form 4: Ameresco Director Sells Shares After Option Exercise

Ameresco Director Nickolas Stavropoulos exercised stock options and subsequently sold 16,100 shares of Class A Common Stock under a pre-arranged 10b5-1 trading plan.

Summary

• Director Nickolas Stavropoulos of Ameresco, Inc. (AMRC) reported transactions involving Class A Common Stock.
• On February 19, 2026, Stavropoulos exercised options to acquire 400 shares at $16.33 per share and subsequently sold these 400 shares at $34.00 per share.
• On February 20, 2026, Stavropoulos exercised options to acquire 15,700 shares at $16.33 per share and subsequently sold these 15,700 shares at a weighted average price of $34.15 per share, with prices ranging from $34.00 to $34.53.
• All sales were conducted pursuant to a Rule 10b5-1 trading plan adopted on September 8, 2025.
• Following these transactions, Stavropoulos directly beneficially owns 14,111 shares of Class A Common Stock and 7,355 stock options.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a routine insider transaction, reflecting the director's exercise of vested options and subsequent sale for personal financial planning, rather than a signal of company performance. The pre-planned nature mitigates any negative sentiment typically associated with insider sales.

Positives

• Director Nickolas Stavropoulos realized value from vested stock options, indicating a successful compensation structure.
• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, enhancing transparency and demonstrating that the sales were not based on new, non-public information.
• The sale prices ($34.00 and $34.15 weighted average) are significantly higher than the exercise price ($16.33), indicating a substantial gain for the director.

Negatives

• The sale of 16,100 shares by a director could be perceived by some investors as a lack of confidence, although the 10b5-1 plan mitigates this concern.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

StockSavvy.ai notes that insider sales, especially those executed under a Rule 10b5-1 trading plan, are common and often reflect personal financial planning and diversification strategies rather than a negative outlook on the company's future performance. Such pre-arranged plans are a standard mechanism for executives to manage their equity holdings while avoiding accusations of trading on material non-public information.

Comparison to Industry Standards

• The use of a Rule 10b5-1 trading plan for insider sales is a widely accepted corporate governance practice, aligning with industry standards for transparency and compliance with insider trading regulations.

Stakeholder Impact

• Shareholders may observe a minor increase in the public float due to the sale of shares, but the overall impact on the company's stock price or fundamental value is likely minimal given the routine nature of the transaction and the volume relative to total shares outstanding.

Key Dates

Recommendation

The filing details routine insider transactions by a director, involving the exercise of stock options and subsequent sale of shares under a pre-arranged 10b5-1 trading plan. This type of transaction is common for executive compensation and does not typically signal a change in the company's fundamental outlook, thus warranting a 'hold' recommendation based solely on this filing.

Keywords

Ameresco, AMRC, Form 4, Insider Trading, Stock Options, Share Sale, Director Transaction, 10b5-1 Plan